A Randomized Study of Lubiprostone for Opioid‐Induced Constipation in Patients with Chronic Noncancer Pain
Author(s) -
Cryer Byron,
Katz Seymour,
Vallejo Ricardo,
Popescu Anca,
Ueno Ryuji
Publication year - 2014
Publication title -
pain medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.893
H-Index - 97
eISSN - 1526-4637
pISSN - 1526-2375
DOI - 10.1111/pme.12437
Subject(s) - lubiprostone , medicine , placebo , constipation , gastroenterology , abdominal pain , adverse effect , irritable bowel syndrome , chronic constipation , alternative medicine , pathology
To evaluate the efficacy and safety of oral lubiprostone for relieving symptoms of opioid-induced constipation (OIC) in patients with chronic noncancer pain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom